# Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)

> **NCT06107010** · NA · RECRUITING · sponsor: **Wandercraft** · enrollment: 66 (estimated)

## Conditions studied

- Stroke, Acute
- Stroke, Ischemic
- Stroke, Subacute
- Stroke Hemorrhagic
- Cerebrovascular Disorders
- Cerebrovascular Accident
- Hemiparesis
- Hemiparesis;Poststroke/CVA
- Hemiparesis/Hemiplegia (One Sided Weakness/Paralysis)

## Interventions

- **DEVICE:** Use of the Atalante exoskeleton

## Key facts

- **NCT ID:** NCT06107010
- **Lead sponsor:** Wandercraft
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-12
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107010, "Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06107010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*